Other
Enhanced Standard Care (ESC)
Total Trials
2
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(2)
Detailed Status
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
withdrawn150%
terminated150%
Recent Activity
0 active trials
Showing 2 of 2
terminatednot_applicable
Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
NCT03455985
withdrawnnot_applicable
Evaluating Models for Dissemination of Injury Prevention Information in the Pediatric Emergency Department Setting
NCT00476255
Clinical Trials (2)
Showing 2 of 2 trials
NCT03455985Not Applicable
Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
NCT00476255Not Applicable
Evaluating Models for Dissemination of Injury Prevention Information in the Pediatric Emergency Department Setting
All 2 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 2